Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs

被引:133
|
作者
Rupniak, NMJ
Carlson, EJ
Webb, JK
Harrison, T
Porsolt, RD
Roux, S
de Felipe, C
Hunt, SP
Oates, B
Wheeldon, A
机构
[1] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
[2] Porsolt & Partners 9 Bis, Boulogne, France
[3] Univ Miguel Hernandez, CSIC, Inst Neurociencias, E-03550 San Juan, Spain
[4] UCL, Dept Anat & Dev Biol, London, England
[5] Merck Res Labs, Rahway, NJ USA
来源
BEHAVIOURAL PHARMACOLOGY | 2001年 / 12卷 / 6-7期
关键词
NK1; receptor; depression; anxiety; L-760735; GR205171; guinea-pig; hamster; mouse; rat; gerbil;
D O I
10.1097/00008877-200111000-00011
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The phenotype of NKIR -/- mice was compared with that of acute pharmacological blockade of the tachykinin NK1 receptor on sensorimotor function and in assays relevant to depressive illness and anxiety. The dose range for L-760735 and GR205171 that was associated with functional blockade of central NK1 receptors in the target species was established by antagonism of the behavioural effects of intracerebroventricular NK1 agonist challenge in gerbils, mice and rats. The caudal grooming and scratching response to GR73632 was absent in NK1R -/- mice, confirming that the receptor had been genetically ablated. There was no evidence of sedation or motor impairment in NK1R -/- mice or following administration of L-760735 to gerbils, even at doses in excess of those required for central NK1 receptor occupancy. In the resident-intruder and forced swim test, the behaviour of NK1R -/- mice, or animals treated acutely with L-760735 or GR205171, resembled that seen with the clinically used antidepressant drug fluoxetine. However, the effects of GR205171 were not clearly enantioselective in mice. In contrast, although NK1R -/- mice also exhibited an increase in the duration of struggle behaviour in the tail suspension test, this was not observed following pharmacological blockade with L-760735 in gerbils or GR205171 in mice, suggesting that this may reflect a developmental alteration in the knockout mouse. There was no effect of NK1 receptor blockade with L-760735 in guinea-pigs or GR205171 in rats, or deletion of the NK1 receptor in mice, on behaviour in the elevated plus-maze test for anxiolytic activity. These findings extend previous observations on the phenotype of the NK1R -/- mouse and establish a broadly similar profile following acute pharmacological blockade of the receptor. These studies also serve to underscore the limitations of currently available antagonists that are suitable for use in rat and mouse behavioural assays. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:497 / 508
页数:12
相关论文
共 50 条
  • [41] Comparison of selective neurokinin receptor antagonists (NK1, NK2, NK3) and mixed profile antagonists (NK1/2, NK1/2/3) in a model of visceral hypersensitivity in rats
    Reiche, Dania
    Jasserand, Daniel
    Sann, Holger
    Preuschoff, Ulf
    Antel, Jochen
    GASTROENTEROLOGY, 2006, 130 (04) : A338 - A338
  • [42] Substance P-induced downregulation of the substance P NK1 receptor expressed in epithelial cells.
    Hardison, JL
    Strausbaugh, HJ
    Grady, EF
    Bunnett, NW
    Vigna, SR
    GASTROENTEROLOGY, 1996, 110 (04) : A1078 - A1078
  • [43] Chemoreceptor activity is normal in mice lacking the NK1 receptor
    Rigual, R
    Rico, AJ
    Prieto-Lloret, J
    de Felipe, C
    González, C
    Donnelly, DF
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (11) : 2078 - 2084
  • [44] Role of the cytoplasmic carboxyl-terminus of the substance P NK1 receptor in receptor regulation.
    Vigna, SR
    Romac, JMJ
    Liddle, RA
    GASTROENTEROLOGY, 1996, 110 (04) : A1130 - A1130
  • [45] PHARMACOLOGICAL EVIDENCE THAT GOLD PROTEIN SUBSTANCE-P COMPLEX ACTIVATES NEUROKININ NK1 RECEPTORS
    CATHIENI, MM
    MASTRANGELO, D
    TABAN, CH
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 1995, 5 (02) : 85 - 95
  • [46] FK-224, A NOVEL CYCLOPEPTIDE SUBSTANCE-P ANTAGONIST WITH NK1 AND NK2 RECEPTOR SELECTIVITY
    MORIMOTO, H
    MURAI, M
    MAEDA, Y
    YAMAOKA, M
    NISHIKAWA, M
    KIYOTOH, S
    FUJII, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (01): : 398 - 402
  • [47] Use of NK1 knockout mice to analyze substance P-induced edema formation
    Cao, T
    Gerard, NP
    Brain, SD
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (02) : R476 - R481
  • [48] Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression
    Kramer, MS
    Winokur, A
    Kelsey, J
    Preskorn, SH
    Rothschild, AJ
    Snavely, D
    Ghosh, K
    Ball, WA
    Reines, SA
    Munjack, D
    Apter, JT
    Cunningham, L
    Kling, M
    Bari, M
    Getson, A
    Lee, Y
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (02) : 385 - 392
  • [49] Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression
    Mark S Kramer
    Andrew Winokur
    Jeffrey Kelsey
    Sheldon H Preskorn
    Anthony J Rothschild
    Duane Snavely
    Kalyan Ghosh
    William A Ball
    Scott A Reines
    Dennis Munjack
    Jeffrey T Apter
    Lynn Cunningham
    Mitchel Kling
    Mohammed Bari
    Albert Getson
    Yih Lee
    Neuropsychopharmacology, 2004, 29 : 385 - 392
  • [50] μ-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn
    Aicher, SA
    Punnoose, A
    Goldberg, A
    JOURNAL OF NEUROSCIENCE, 2000, 20 (11): : 4345 - 4354